Johnson & Johnson EV/Sales
Cos'è EV/Sales di Johnson & Johnson?
EV/Sales di Johnson & Johnson è 5.93
Qual è la definizione di EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales di aziende nel Health Care settore su NYSE rispetto a Johnson & Johnson
Cosa fa Johnson & Johnson?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Aziende con ev/sales simili a Johnson & Johnson
- Paramount Inc ha EV/Sales di 5.92
- Mcphy S.A. Eo 0,12 ha EV/Sales di 5.92
- Crossword Cybersecurity Plc ha EV/Sales di 5.92
- iShares € Corp Bond 0-3yr ESG UCITS ETF EUR (Dist) ha EV/Sales di 5.93
- Budweiser Brewing APAC ha EV/Sales di 5.93
- Vixtel Technologies ha EV/Sales di 5.93
- Johnson & Johnson ha EV/Sales di 5.93
- ASM International NV ha EV/Sales di 5.94
- SiteMinder ha EV/Sales di 5.94
- Aon plc ha EV/Sales di 5.94
- Atlas ha EV/Sales di 5.94
- Housing Development Finance ha EV/Sales di 5.94
- Avid Bioservices Inc ha EV/Sales di 5.94